D Lebeaux

Summary

Country: France

Publications

  1. doi request reprint In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections
    David Lebeaux
    Institut Pasteur, Genetics of Biofilms Unit, Department of Microbiology, 28 rue du Dr Roux, 75724 Paris Cedex 15, France Sorbonne Paris Cite, AP HP, Hopital Necker Enfants Malades, Centre d Infectiologie Necker Pasteur and Institut Imagine, Universite Paris Descartes, 149 rue de Sevres, 75743 Paris Cedex 15, France
    J Antimicrob Chemother 70:1704-12. 2015
  2. doi request reprint Nocardiosis in transplant recipients
    D Lebeaux
    Sorbonne Paris Cité, AP HP, Hopital Necker Enfants Malades, Centre d Infectiologie Necker Pasteur and Institut Imagine, Universite Paris Descartes, 149, rue de Sevres, 75743, Paris Cedex 15, France
    Eur J Clin Microbiol Infect Dis 33:689-702. 2014
  3. doi request reprint Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature
    David Lebeaux
    Service de Medecine Interne, Hopital Bichat Claude Bernard, AP HP, Paris, France
    Medicine (Baltimore) 91:309-18. 2012
  4. doi request reprint [Totally implanted access port-related infections: features and management]
    D Lebeaux
    Service de Medecine Interne, Hopital Beaujon, AP HP, 100, boulevard du General Leclerc, 92110 Clichy, France
    Rev Med Interne 31:819-27. 2010

Detail Information

Publications4

  1. doi request reprint In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections
    David Lebeaux
    Institut Pasteur, Genetics of Biofilms Unit, Department of Microbiology, 28 rue du Dr Roux, 75724 Paris Cedex 15, France Sorbonne Paris Cite, AP HP, Hopital Necker Enfants Malades, Centre d Infectiologie Necker Pasteur and Institut Imagine, Universite Paris Descartes, 149 rue de Sevres, 75743 Paris Cedex 15, France
    J Antimicrob Chemother 70:1704-12. 2015
    ....
  2. doi request reprint Nocardiosis in transplant recipients
    D Lebeaux
    Sorbonne Paris Cité, AP HP, Hopital Necker Enfants Malades, Centre d Infectiologie Necker Pasteur and Institut Imagine, Universite Paris Descartes, 149, rue de Sevres, 75743, Paris Cedex 15, France
    Eur J Clin Microbiol Infect Dis 33:689-702. 2014
    ..Because of a high recurrence rate, antibiotic therapy should be prescribed for 6 to 12 months...
  3. doi request reprint Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature
    David Lebeaux
    Service de Medecine Interne, Hopital Bichat Claude Bernard, AP HP, Paris, France
    Medicine (Baltimore) 91:309-18. 2012
    ..Candida species and CoNS were responsible for severe sepsis or septic shock...
  4. doi request reprint [Totally implanted access port-related infections: features and management]
    D Lebeaux
    Service de Medecine Interne, Hopital Beaujon, AP HP, 100, boulevard du General Leclerc, 92110 Clichy, France
    Rev Med Interne 31:819-27. 2010
    ..Future studies must focus on defining more precisely the factors associated with salvage therapy failure including host, pathogens virulence factors and biofilm formation...